VERAVAS Trademark

Trademark Overview


On Friday, March 8, 2024, a trademark application was filed for VERAVAS with the United States Patent and Trademark Office. The USPTO has given the VERAVAS trademark a serial number of 98440683. The federal status of this trademark filing is REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION as of Thursday, October 9, 2025. This trademark is owned by Veravas, Inc.. The VERAVAS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research information in the field of neurodegenerative treatment and diagnosis; Product design and development in the field of genomics; Product design and development in the field of pharmacogenomics; Product design and development in the field of diagnostics; Product design and development in the field of clinical trial design; Product design and development in the field of biotechnology; Product design and development in the field of biomedical science; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing reagent sample testing and diagnostic services for others for scientific research purposes
veravas

General Information


Serial Number98440683
Word MarkVERAVAS
Filing DateFriday, March 8, 2024
Status802 - REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION
Status DateThursday, October 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 9, 2025

Trademark Statements


Goods and ServicesMedical and scientific research information in the field of neurodegenerative treatment and diagnosis; Product design and development in the field of genomics; Product design and development in the field of pharmacogenomics; Product design and development in the field of diagnostics; Product design and development in the field of clinical trial design; Product design and development in the field of biotechnology; Product design and development in the field of biomedical science; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing reagent sample testing and diagnostic services for others for scientific research purposes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 8, 2024
Primary Code042
First Use Anywhere DateThursday, September 21, 2017
First Use In Commerce DateThursday, September 21, 2017

Trademark Owner History


Party NameVeravas, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAustin, TX 78701

Party NameVeravas, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 78701

Trademark Events


Event DateEvent Description
Friday, March 8, 2024NEW APPLICATION ENTERED
Tuesday, July 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 21, 2024ASSIGNED TO EXAMINER
Friday, September 27, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 27, 2024NON-FINAL ACTION WRITTEN
Friday, September 27, 2024NON-FINAL ACTION E-MAILED
Friday, December 27, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 15, 2025FINAL REFUSAL E-MAILED
Wednesday, January 15, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, December 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 15, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, January 15, 2025FINAL REFUSAL WRITTEN
Tuesday, April 15, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 15, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 11, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 9, 2025PUBLISHED FOR OPPOSITION
Thursday, October 9, 2025EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, September 9, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 3, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED